Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Atyr Pharma Inc Cmn (LIFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 83,125
  • Shares Outstanding, K 23,750
  • Annual Sales, $ 0 K
  • Annual Income, $ -57,860 K
  • 36-Month Beta 3.74
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.28

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.00 +9.17%
on 04/24/17
3.55 -7.75%
on 04/27/17
-0.27 (-7.75%)
since 03/28/17
3-Month
2.95 +11.02%
on 01/30/17
4.45 -26.40%
on 02/28/17
+0.28 (+9.17%)
since 01/27/17
52-Week
2.10 +55.95%
on 12/21/16
4.45 -26.40%
on 02/28/17
-0.48 (-12.90%)
since 04/28/16

Most Recent Stories

More News
Genovis AB Initiates Sales of GlyCLICK(TM)

GlyCLICK is the first of a series of products based on a technology platform in which Genovis' unique enzyme GlycINATOR(R) is combined with SiteClick(TM) technology from Life Technologies....

LIFE : 3.25 (-7.14%)
BioTelemetry, Inc. Issues Prospectus for Public Tender Offer to Acquire LifeWatch AG

BioTelemetry, Inc. (NASDAQ:BEAT) and LifeWatch AG (SIX:LIFE) announced today that BioTelemetry published the prospectus for the public tender offer for all publicly held registered shares of LifeWatch...

BEAT : 32.92 (+1.45%)
LFWWF : 12.7600 (unch)
LIFE : 3.25 (-7.14%)
BioTelemetry, Inc. Launches a Tender Offer to Acquire LifeWatch AG

BioTelemetry, Inc. (NASDAQ:BEAT) and LifeWatch AG (SIX:LIFE) announced today that the companies have entered into a definitive transaction agreement under which BioTelemetry will launch a tender offer...

BEAT : 32.92 (+1.45%)
LFWWF : 12.7600 (unch)
LIFE : 3.25 (-7.14%)
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the appointment...

LIFE : 3.25 (-7.14%)
aTyr Pharma to Present at Needham and Company 16th Annual Healthcare Conference

aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the Company's presentation...

LIFE : 3.25 (-7.14%)
Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors

Fluidigm Corporation (NASDAQ:FLDM) today announced that Nicolas Barthelemy and Dr. Carlos Paya have been appointed to its Board of Directors.

SARTF : 82.1500 (-1.91%)
RGEN : 36.83 (-0.16%)
LIFE : 3.25 (-7.14%)
FLDM : 4.98 (-1.97%)
aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced operating results...

LIFE : 3.25 (-7.14%)
aTyr Pharma Receives EMA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris(TM)

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced that the European...

LIFE : 3.25 (-7.14%)
aTyr Pharma to Present at Cowen and Company 37th Annual Health Care Conference

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the Company's presentation...

LIFE : 3.25 (-7.14%)
High court ruling limits international reach of patent laws

WASHINGTON (AP) — The Supreme Court on Wednesday sided with California-based Life Technologies Corp. in a patent infringement case that limits the international reach of U.S. patent laws.

LIFE : 3.25 (-7.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

See More

Support & Resistance

2nd Resistance Point 3.63
1st Resistance Point 3.57
Last Price 3.25
1st Support Level 3.42
2nd Support Level 3.33

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.